Localization of Hyperparathyroid Lesions
Article Sidebar
Published:
Jun 1, 2018
Keywords:
Parathyroid gland parathyroid adenoma parathyroid hyperplasia parathyroid scintigraphy
Main Article Content
Abstract
Localization of parathyroid lesions is essential for the surgical planning in hyperparathyroidism. Multimodalities have been used to localize parathyroid lesions such as ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), radionuclide scintigraphy. In the recent years, 4D computed tomography scan is the new method used to localize parathyroid lesions. Each method has both advantages and disadvantages, hence, the method for localization of parathyroid lesions should be considered as the most suitable for individual situation.
Article Details
How to Cite
Chochai, P. (2018). Localization of Hyperparathyroid Lesions. Vajira Medical Journal : Journal of Urban Medicine, 62(Supplement), S19–32. Retrieved from https://he02.tci-thaijo.org/index.php/VMED/article/view/209282
Section
Review Articles
References
1. Merino M, Quezado M, Rubin E,Rubin R. Rubin’s pathology: clinicopathologic fundamental of medicine, 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008, p.955-8.
2. Chan JKC. Tumors of the thyroid and parathyroid glands. In: Fletcher DM, ed. Diagnostic histopathology of tumors. 3rd ed. New York: Churchill Livingstone; 2007; chap 18.
3. Hindie E, Ugur O, Fuster D, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009; 36: 1201-16.
4. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester,
5. Eslamy HK, Ziessman HA. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Radiographics. 2008; 28: 1461-76.
6. Smith FR, Oates E. Radionuclide imaging of the parathyroid glands: Patterns, Pearls, and Pitfalls. Radiographics. 2004; 24: 1101-15.
7. Bilezikian JP, Khan AA, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the third international workshop; J Clin Endocrinol Metab. 2009; 2: 335-9.
8. Bozkurt MF, Ugur O, Hamaloglu E, Sayek I, Gulee SA. Optimization of the gamma probe-guided parathyroidectomy. Am Surg. 2003; 69: 720-5.
9. Loney EL, Dick EA, Francis IS, Buscombe JR. Localization of parathyroid nodules. Radiology. 2001; 218: 916-7.
10. De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, et al. Parathyroid glands: combination of 99mTc MIBI glands and nodules. Radiology. 2000; 214:393-402.
11. Tomasella G. Diagnostic imaging in primary hyperparathyroidism. Radiological techniques: US-CAT-MR [in Italian]. Minerva Endocrinol. 2001; 26:3-12.
12. Hopkins RC, Reading CC. Thyroid and parathyroid imaging. Semin Ultrasound CT MR. 1995; 16(4):279-95.
13. Malinzak MD, Sosa JA, Hoang J. 4D-CT for Detection of Parathyroid Adenoma and Hyperplasia: State of the Art Imaging. Curr Radiol Rep. 2017; 5(8):1-11.
14. Mc Biles M, Lambert AT, Cote MG, Kim SY. Sestamibi parathyroid Imaging. Seminars in Nuclear medicine. 1995; 3:221-34.
15. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, Dackiw AP, Tufano RP, Zeiger MA, Ziessman HA.Comparison of SPECT/CT, SPECT and planar imaging with single- and dual-phase 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;7: 1084-9.
16. Scott MW, Tracy SW, Daniel TR, James AL, Sylvia LA, Quan-Yang D, et al. The American Association of Endocrine Surgeons Guidelines for Definite Management of Primary Hyperparathyroidism. JAMA Surg. 2016; 151(10): 959-68
17. Saliba W, El-Haddad B. Secondary hyperparathyroid: pathophysiology and treatment. JABFM. 2009; 5: 574-81.
18. Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. Kidney Int Suppl, 2017; Suppl. 7, 1–59
2. Chan JKC. Tumors of the thyroid and parathyroid glands. In: Fletcher DM, ed. Diagnostic histopathology of tumors. 3rd ed. New York: Churchill Livingstone; 2007; chap 18.
3. Hindie E, Ugur O, Fuster D, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009; 36: 1201-16.
4. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester,
5. Eslamy HK, Ziessman HA. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Radiographics. 2008; 28: 1461-76.
6. Smith FR, Oates E. Radionuclide imaging of the parathyroid glands: Patterns, Pearls, and Pitfalls. Radiographics. 2004; 24: 1101-15.
7. Bilezikian JP, Khan AA, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the third international workshop; J Clin Endocrinol Metab. 2009; 2: 335-9.
8. Bozkurt MF, Ugur O, Hamaloglu E, Sayek I, Gulee SA. Optimization of the gamma probe-guided parathyroidectomy. Am Surg. 2003; 69: 720-5.
9. Loney EL, Dick EA, Francis IS, Buscombe JR. Localization of parathyroid nodules. Radiology. 2001; 218: 916-7.
10. De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, et al. Parathyroid glands: combination of 99mTc MIBI glands and nodules. Radiology. 2000; 214:393-402.
11. Tomasella G. Diagnostic imaging in primary hyperparathyroidism. Radiological techniques: US-CAT-MR [in Italian]. Minerva Endocrinol. 2001; 26:3-12.
12. Hopkins RC, Reading CC. Thyroid and parathyroid imaging. Semin Ultrasound CT MR. 1995; 16(4):279-95.
13. Malinzak MD, Sosa JA, Hoang J. 4D-CT for Detection of Parathyroid Adenoma and Hyperplasia: State of the Art Imaging. Curr Radiol Rep. 2017; 5(8):1-11.
14. Mc Biles M, Lambert AT, Cote MG, Kim SY. Sestamibi parathyroid Imaging. Seminars in Nuclear medicine. 1995; 3:221-34.
15. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, Dackiw AP, Tufano RP, Zeiger MA, Ziessman HA.Comparison of SPECT/CT, SPECT and planar imaging with single- and dual-phase 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;7: 1084-9.
16. Scott MW, Tracy SW, Daniel TR, James AL, Sylvia LA, Quan-Yang D, et al. The American Association of Endocrine Surgeons Guidelines for Definite Management of Primary Hyperparathyroidism. JAMA Surg. 2016; 151(10): 959-68
17. Saliba W, El-Haddad B. Secondary hyperparathyroid: pathophysiology and treatment. JABFM. 2009; 5: 574-81.
18. Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. Kidney Int Suppl, 2017; Suppl. 7, 1–59